BDF Gestion Sells 1,876 Shares of Danaher Corporation $DHR

Key Points

• BDF Gestion reduced its stake in Danaher Corporation by 9.8%, selling 1,876 shares, leaving them with 17,215 shares valued at approximately $3.4 million.
• Danaher reported a quarterly earnings per share of $1.80, exceeding estimates and showing a 3.4% revenue increase year-over-year, with guidance suggesting a projected EPS of 7.63 for the current year.
• The company declared a quarterly dividend of $0.32 per share, translating to an annualized payout of $1.28, with a dividend yield of 0.7%.

BDF Gestion cut its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 9.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,215 shares of the conglomerate's stock after selling 1,876 shares during the period. BDF Gestion's holdings in Danaher were worth $3,401,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. raised its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC bought a new stake in Danaher in the fourth quarter valued at approximately $27,000. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the 1st quarter valued at $31,000. Finally, Dunhill Financial LLC boosted its holdings in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

Danaher stock opened at $193.31 on Friday. The stock has a 50-day moving average price of $200.17 and a two-hundred day moving average price of $198.39. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a market capitalization of $138.42 billion, a PE ratio of 41.13, a P/E/G ratio of 2.72 and a beta of 0.75. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's payout ratio is 27.23%.

Analysts Set New Price Targets

DHR has been the topic of a number of recent research reports. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Robert W. Baird lifted their price objective on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Finally, Barclays restated an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.